Mobilizing social support networks to improve cancer screening: the COACH randomized controlled trial study design by Olive Mbah et al.
STUDY PROTOCOL Open Access
Mobilizing social support networks to
improve cancer screening: the COACH
randomized controlled trial study design
Olive Mbah1*, Jean G. Ford2, Miaozhen Qiu3, Jennifer Wenzel1,4, Lee Bone5, Janice Bowie5, Ahmed Elmi1,
Jimmie L. Slade6, Michele Towson7 and Adrian S. Dobs8
Abstract
Background: Disadvantaged populations face many barriers to cancer care, including limited support in navigating
through the complexities of the healthcare system. Family members play an integral role in caring for patients and
provide valuable care coordination; however, the effect of family navigators on adherence to cancer screening has
not previously been evaluated. Training and evaluating trusted family members and other support persons may
improve cancer outcomes for vulnerable patients.
Methods: Guided by principles of community based participatory research (CBPR), “Evaluating Coaches of Older
Adults for Cancer Care and Healthy Behaviors (COACH)” is a community-based randomized controlled trial to assess
the effectiveness of a trained participant-designated coach (support person or care giver) in navigating cancer-
screening for older African American adults, 50–74 years old. Participants are randomly assigned as dyads
(participant + coach pair) to receiving either printed educational materials only (PEM—control group) or educational
materials plus coach training (COACH—intervention group). We defined a coach as family member, friend, or other
lay support person designated by the older adult. The coach training is designed as a one-time, 35- to 40-minute
training consisting of: 1) a didactic session that covers the role of the coach, basic facts about colorectal, breast and
cervical cancers (including risk factors, signs and symptoms and screening modalities), engaging the healthcare
provider in cancer screening, insurance coverage for screening, and related healthcare issues, 2) three video skits
addressing misconceptions about and planning for cancer screening, and 3) an interactive role-play session with
the trainer to reinforce and practice strategies for encouraging the participant to get screened. The primary study
outcome is the difference in the proportion of participants completing at least one of the recommended
screenings (for breast, cervix or colorectal cancer) between the control and intervention groups.
Discussion: Building on trusted patient contacts to encourage cancer screening, COACH is a highly sustainable
intervention in a high-risk population. It has the potential to minimize the effect of mistrust of the medical
establishment on screening behaviors by mobilizing participants’ existing support networks. If effective, the
intervention could have a high impact on health care disparities research across multiple diseases.
Trial registration: ClinicalTrials.gov (NCT01613430). Registered June 5, 2012
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Background
Cancer is the second leading cause of death in the
United States, and accounts for one in every four deaths
[1]. Advances in early diagnosis and treatment have led
to declining mortality rates over the past two decades, but
racial/ethnic disparities persist [2–5]. By 2030, cancer inci-
dence is expected to increase by 99 % among minorities
(vs. 31 % for whites) [6]. Compared to other racial/ethnic
groups, African Americans have the highest death rates
and shortest survival for most cancers [1, 7]. When strati-
fied by age and race, older African Americans bear the
highest mortality burden [8]. Reasons for these ongoing
disparities are multifactorial but inadequate secondary
prevention through screening and late diagnosis have been
shown to play an important role [7, 9–14], highlighting
the need for effective and sustainable interventions.
Among the many unique barriers that minority popu-
lations face in cancer care are difficulties navigating
through the complexities of the healthcare system [15].
The use of care coordination models, including commu-
nity health workers (CHW) or patient navigators (PN),
have demonstrated positive outcomes. These include
bridging health care systems and racial/ethnic minority
communities in various settings, including for cancer
screening [15–19] and diagnostic follow up [18, 20–23].
However, prior patient data revealed that trusted social
network members play an even more integral role in
caring for patients and may be the most effective at help-
ing to coordinate care and address their cancer-related
needs [24, 25]. As care has shifted from the hospital to the
home, caregivers have been tasked with complex, multifa-
ceted responsibilities that many are ill prepared to assume
[24]. Furthermore, our work with African American older
adults suggest that 1) this population considers family and
friends as trusted sources of cancer information and 2)
both urban and rural African American cancer survivors
preferred to work through healthcare access issues with
people with whom they already had a relationship (vs.
CHWs whom they did not know and who did not have
formal health education training) [25, 26]. Additionally,
older adult patients are frequently accompanied by family
members or other support persons to medical appoint-
ments; companions who are verbally active in these visits
are generally effective in improving patient-physician
communication [27]. As the reliance on family caregivers
increases, of noted importance for minority patients,
programs to build caregiver confidence and compe-
tence provide opportunities to address existing gaps
within the healthcare system.
Although a growing body of literature shows the
benefits of caregiver-related interventions, there’s limited
evidence on their effects on outcomes in cancer care,
other than for depression and psychological functioning
[28, 29]. To our knowledge, there are no published
caregiver-related interventions targeting cancer screening.
There is a need for rigorous evidence-based research
describing and evaluating interventions where caregivers
assist in navigating older adults. The “Evaluating Coaches
of Older Adults for Cancer Care and Healthy Behaviors
(COACH)” study also addresses the essential need to
evaluate the effects of such interventions on caregiver out-
comes [30]. The central hypothesis of the COACH study
is that members of older adults’ extended families or sup-
port networks can be trained to be effective coaches, who
provide support through the cancer control continuum
(i.e., prevention, screening, diagnosis and treatment). The
primary outcome of the study is adherence to cancer
screening.
Methods
Study design, population and setting
The COACH study is an ongoing community-based ran-
domized controlled trial to assess the effectiveness of
trained participant-designated coaches vs. the more stand-
ard intervention of distributing printed educational mate-
rials in improving cancer-screening behaviors. Participants
are randomly assigned as dyads (participant + coach pair)
to receiving either printed educational materials only
(PEM—control group) or educational materials plus coach
training (COACH—intervention group) Fig. 1. The study
population consists of African American older adults 50
to 74 years old who reside in Baltimore City or Prince
George’s County, Maryland. The populations of both
Baltimore City and Prince George’s County are approxi-
mately 63 and 65 % African American respectively.
Baltimore City’s overall socioeconomic status is lower
than that of Prince George’s County as indicated by
median household income ($41,385 vs. $73,623) and
percent of persons living below the poverty line (23.8
vs. 9.4 %) [31, 32]. Nevertheless, compared to the
overall population of the U.S. and of the State of
Maryland, both counties show higher age-adjusted
cancer mortality rates for breast, cervix and colorectal
cancer [33]. The similarities in cancer risk and mortality
profiles between these two counties offer a potentially re-
warding context for: 1) disaggregating the effects of race/
ethnicity vs. socioeconomic status as determinants of ad-
verse health outcomes; and 2) evaluating how the effects
of interventions to reduce cancer disparities may vary by
socioeconomic status. Other inclusion criteria for the
study are: eligibility for breast, cervical or colorectal can-
cer screening at time of enrollment, and having a support
person (coach) who is available to participate in the study.
Coaches can be a family member, friend, neighbor or
other lay support person designated by the participant. Ex-
clusion criteria include a diagnosis of cancer within the
past 5 years or a diagnosis of cancer not in remission, an
inability to provide informed consent, or current residence
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in a chronic care facility or otherwise institutionalized.
The rationale for excluding individuals who are institu-
tionalized is that they may already be receiving specific in-
terventions or face special barriers that affect the outcome
variables of interest. To preserve the integrity of the trial,
only one individual per household is eligible to participate.
Randomization is stratified by county and gender.
Recruitment
Participants were recruited into the study between June
2012 and July 2015 using both convenience- and a
quasi-population- based sampling. Recruitment began
with a cohort of participants from a previous cancer
screening study (the Cancer Prevention and Treatment
Demonstration (CPTD) Screening Trial control group
participants, described in detail here— [19, 34]) who had
agreed to be contacted for future studies and were
within the age group for the COACH study. These indi-
viduals were contacted by phone to determine their
interest in and eligibility for the COACH study. Other
convenience sampling was conducted in collaboration
with our community partners and consisted of targeted
outreach events at community centers, churches, senior
residential buildings, health fairs, and other events and
locations that included our target population. Potential
participants were introduced to the study and given the
opportunity to be screened for eligibility. The quasi-
population-based sampling entailed using commercially
obtained rosters of our target population for study re-
cruitment. This data was purchased from Aristotle Inter-
national, a private company that specializes in compiling
and managing voter and consumer information. The
Fig. 1 Evaluating Coaches of Older Adults for Cancer Care and Healthy Behaviors (COACH) Study Design Flow Chart
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data included names and contact information for African
American residents of Baltimore City and Prince George’s
County, Maryland who were 50–74 years old. These
potential participants were initially contacted by letter to
introduce the study and provided with an opportunity to
opt out of being called for recruitment by study staff.
Individuals who did not opt out within a week were then
contacted by phone to determine their interest in and
eligibility for the study. All potential participants were
screened for eligibility by phone (predominantly) or in
person. Eligible individuals were consented in person,
administered the baseline interview and then randomized
1:1 to either the PEM or COACH group. Participants are
enrolled in the study for one year and are administered a
6-month and 1-year follow up interviews. The COACH
study was approved by the Johns Hopkins School of
Public Health’s Institutional Review Board.
Interventions
Printed educational materials (PEM)
Participants randomized to the control group receive
educational brochures on colorectal [35], breast [36] and
cervical cancer [37] screenings produced by the National
Cancer Institute (breast), Centers for Medicare and Me-
dicaid Services (cervical) and the Centers for Disease
Control and Prevention (colorectal).
Coach training
Intervention group participants receive the same PEM
plus the training of their coaches, a cancer screening re-
minder postcard 6 weeks after enrollment into the study,
and the opportunity to call study staff with any ques-
tions related to screening. The coach training is a one-
time, in-person, 35- to 40-min training administered to
the coach at the time of participant enrollment. Training
includes: 1) a didactic session that covers the role of the
coach, basic information on colorectal, breast and cer-
vical cancers (including risk factors, signs and symptoms
and screening modalities and frequency), how to prepare
for a medical visit, discussing cancer screening with a
healthcare provider, insurance coverage and no cost
screening resources, and related healthcare issues, 2)
three video skits (4 min total) addressing misconceptions
around cancer screening and working with a healthcare
provider and support person to plan for screening, and
3) an interactive role-play session with the trainer to
emphasize strategies for encouraging the participant to
get screened. The video skits and role-play help
reinforce and practice strategies for encouraging the par-
ticipant to get screened. Coaches are administered a pre-
and post- assessment to evaluate change in knowledge
and understanding of the material. As part of the train-
ing, coaches are given a packet that includes: a copy of
the didactic presentation, cancer screening brochures, a
points-to-remember sheet to document cancer screening
questions for the participant’s healthcare provider and
provider recommendations, a suggested task list for the
coach, and resources that address well-known barriers to
screening such as insurance coverage and transportation.
Participants whose coaches disenroll from the study are
given an opportunity to have a new support person
trained as a coach. To standardize the coach training, all
study staff who administer the training are provided with
detailed guiding scripts that cover all aspects of the
training. Intervention coaches are also provided with in-
formation to contact study staff with screening-related
questions. Cancer screening guidelines in the coach
training are based on recommendations from the U.S.
Preventive Services Task Force [38] and the American
Cancer Society [39]. These recommendations include:
colorectal screening in adults beginning at age 50 (fre-
quency depends on modality), breast cancer screening be-
ginning at age 40 every 1–2 years, and cervical cancer
screening beginning at 21 every 3–5 years (with a recom-
mendation for women 65 and over to consult with their
doctors). Given the expected diversity in cancer risk
among study participants and differences in screening rec-
ommendations, the intervention was designed to address
individual provider-driven recommendations for cancer
screenings (i.e., coaches are encouraged and provided with
tools to discuss cancer screening with the participant's
healthcare provider).
Integration of community based participatory research
principles
The COACH study is anchored in the principles of
Community Based Participatory Research (CBPR) [40, 41].
The study was designed with the active participation of
community partners, including representatives of major
organizations and health care institutions as well as com-
munity members from Baltimore City and Prince George’s
County. Participation of community partners occurred at
the level of: 1) problem definition and conceptualization;
2) collaborative review of preliminary data; 3) formulation
of study hypotheses; 4) development of draft proposal for
the study; and, 5) formation of two Community Advisory
Groups (one in each study jurisdiction) to oversee the
study. The formative phase of the study included key
informant in-depth interviews with 12 health practi-
tioners and community leaders within the two counties.
Interviews explored the feasibility of the study design, bar-
riers to screening, issues for training participant-designated
coaches and providing feedback on the baseline question-
naires. The two broadly representative Community Advis-
ory Groups (CAGs) continue to help guide all phases of
the study, including review of study documents. Commu-
nity Advisory Group members include representatives
from community associations, faith-based organizations,
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local health departments and senior housing facilities, non-
profit organizations, local hospitals and clinics, as well as
community members.
Data collection and study measures
All participants (including coaches) are administered a
baseline, 6-month and 1-year exit interview. The base-
line interview is conducted in person, the 6-month by
phone and the exit interview either in-person or by
phone. In-person interviews are conducted primarily at
participants’ homes or study site located at a community
health center. The primary focus of the interview ques-
tionnaires is to ascertain information on intermediary
and outcome variables for the study, including measures
for predisposing, reinforcing, and enabling factors for
cancer screening. Under predisposing factors, measures
of knowledge, attitudes, beliefs about cancer screening,
physical and emotional functional health, cancer risk
and past screening behaviors are collected. Re-enforcing
factors include measures of trust in the health care system
and perceived discrimination—both of which can be
powerful predictors of adherence to treatment recommen-
dations [42, 43], satisfaction with care, available support to
navigate the health system and perceived self-efficacy to
accomplish cancer screening. Enabling factors include
items to assess the perceived ease of accessing health care
services, the availability and cost associated with care, the
perceived ease of scheduling health care appointments,
and a standard checklist of co-morbid conditions. Other
variables collected include health literacy, cognitive
functioning, perceived stress and sociodemographic char-
acteristics (age, gender, ethnicity, race, education, income,
marital status and housing situation). Adherence to
screening is documented through self-report of cancer
screening behaviors; participants’ consent to obtain med-
ical records and Medicare claims data is also obtained.
Questionnaire items are based on published literature and
uses standard instruments and scales when possible.
Outcome variables
The primary research question to be addressed by this
study is whether the COACH intervention will improve
cancer screening adherence compared to the standard
(control) PEM intervention. This primary question will
be assessed by the difference in the proportion of partic-
ipants adhering to at least one of the recommended
screenings, i.e. mammogram, Pap smear, or colorectal
screening. The differences in the cancer screening rates
will be examined with both multivariate regression
methods and survival analysis, specifically to adjust for
withdrawal and right censoring over the study period.
Participants who are lost to follow up will be censored
at their last visit or interview for the study. Missing data
mechanisms (e.g., missing at random (MAR), missing
completely at random (MCAR), and non-ignorable miss-
ingness (MNAR)) will be evaluated. The distribution of
“missingness” will also be assessed by comparing demo-
graphic characteristics and baseline outcome variables
between participants who completed study question-
naires to those lost to follow up for each intervention
arm. To account for missing data, we will consider in-
verse weighted probability for complete case missing
data and multiple imputation methods for item missing
data. The analytic strategy will also include methods for
handling correlation of repeated measures, such as the
Generalized Estimating Equations (GEE) method. All
analyses will be carried out according to intention to
treat (ITT). Given the study’s focus on provider-driven
recommendations for cancer screenings, we included the
following additional primary outcome posterior: the differ-
ence in the proportion of participants who report talking
with their healthcare provider regarding at least one of the
recommended cancer screening(s) between the control
and intervention groups. Similar statistical methods will
be applied here as in the analysis for screening adherence.
All statistical models will be adjusted for potential
confounders based a priori on scientific literature, or
exploratory analysis such as bivariate screening.
Secondary outcome variables will include between-group
differences in the time to completion of screenings, com-
pletion of other preventive screenings, changes in cancer
screening barriers, and changes in the reported levels of
stress for both the participants and coaches. Several out-
comes will also be assessed among the coaches including
differences in cancer screening adherence between coaches
in the intervention and control groups, predictors of
screening at follow up, satisfaction with the intervention,
barriers to screening and other outcomes.
Power calculation
The target sample size for the study is 550 participants
and 550 coaches (total N = 1100 participants). This is the
minimum sample size required to show a 13.6 % in-
crease relative to a 35 % anticipated screening propor-
tion among the PEM group during follow up (based on
calculations in a similar population from our previous
study, the Cancer Prevention and Treatment Demon-
stration) with a 0.05 two-sided significance level, 20 %
Type II error (80 % power), and then taking into account
an anticipated loss to follow up of 20 %. Power calcula-
tions were performed using STATA/SE 11.2 (Stata Cor-
poration, College Station, TX, USA).
Discussion
Cancer disparities are known to result from inequities in
the delivery of and access to high-quality cancer preven-
tion, early detection, and treatment services [1]. Racial
and ethnic minorities are disproportionately represented
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among individuals of low socio-economic status (SES),
and there is a strong association between SES and re-
duced screening rates for all cancers [44, 45], later-stage
diagnosis and poorer survival rates [46–49]. In addition
to socio-economic barriers, any programs to reduce ra-
cial disparities in cancer care among older adults must
mitigate other potential barriers such as management of
multiple comorbidities, limited health literacy and cogni-
tive impairment which have been associated with adverse
cancer prognosis [50–56]. Given the persistence of cancer
disparities, there’s a need for novel, simple, sustainable
and scalable interventions targeted towards helping mi-
norities navigate the healthcare system around cancer-
related care and that also incorporate patient-preferred
support systems. Building on individual and collective
strengths and resources, such as those available through
patients’ communities social networks, is essential to ad-
dressing disparities affecting racial/ethnic minority popu-
lations. Care models such as the use of patient navigators
and CHWs show great promise; however, they have been
adopted only on a limited basis, especially around cancer
prevention. Specific concerns regarding their sustainability
include personnel costs, as well as the variability and vari-
able efficacy of these models [18].
Family-involved interventions in cancer care have
shown promise in improving outcomes for depres-
sion/anxiety, general psychological functioning, rela-
tionship adjustment and patient symptoms such as
pain [28]. Griffin et al. highlight the limited progress
made in the U.S. through family-delivered interven-
tions despite the important role families already dem-
onstrate in cancer patients’ care [28, 29]. Yet few or
no studies have reported on the patient-related cancer
outcome of health care utilization [28]. There is a
need to test the effect of family- or social network-
based interventions on a broad scope of outcomes,
including those related to improving healthcare utilization
among minority cancer patients.
Our central hypothesis centers on the capacity of a
trained participant-designated caregiver or support
person to deliver an effective intervention to improve
coordination of services related to cancer screening
and related comorbidities in a cost-effective manner, a
question which has received scant attention. This is a
logical next step in the natural evolution of caregiver
research and cancer screening interventions. The
COACH model is significant because it evaluates a
highly replicable and sustainable intervention in a
high-risk population. It is innovative because it mini-
mizes the effect of mistrust of the medical establishment
on screening behaviors by mobilizing participants’
social support networks. If participant-designated
coaches are effective in reducing disparities in cancer
screening, this will provide further evidence for the
potential for this low-cost intervention to improve
health-related outcomes for patients and caregivers,
across multiple diseases and conditions.
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